255 related articles for article (PubMed ID: 17487382)
1. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.
Rodríguez-Jiménez FJ; Caldés T; Iniesta P; Vidart JA; Garcia-Asenjo JL; Benito M
Oncol Rep; 2007 Jun; 17(6):1301-7. PubMed ID: 17487382
[TBL] [Abstract][Full Text] [Related]
2. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.
Yamashita K; Upadhay S; Mimori K; Inoue H; Mori M
Cancer; 2003 May; 97(10):2412-9. PubMed ID: 12733139
[TBL] [Abstract][Full Text] [Related]
4. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
5. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
6. Frequent inactivation of RUNX3 in endometrial carcinoma.
Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
[TBL] [Abstract][Full Text] [Related]
7. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
[TBL] [Abstract][Full Text] [Related]
8. The differential expression of SPARC in esophageal squamous cell carcinoma.
Che Y; Luo A; Wang H; Qi J; Guo J; Liu Z
Int J Mol Med; 2006 Jun; 17(6):1027-33. PubMed ID: 16685412
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma.
Shiozawa T; Itoh K; Horiuchi A; Konishi I; Fujii S; Nikaido T
Anticancer Res; 2002; 22(1A):139-43. PubMed ID: 12017277
[TBL] [Abstract][Full Text] [Related]
10. Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells.
Watkins G; Martin TA; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):273-8. PubMed ID: 15763439
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
Saito T; Nishimura M; Yamasaki H; Kudo R
Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
[TBL] [Abstract][Full Text] [Related]
15. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
[TBL] [Abstract][Full Text] [Related]
17. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
18. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.
Ye F; Zhang SF; Xie X; Lu WG
Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347
[TBL] [Abstract][Full Text] [Related]
19. [Methylation and expression of the p16 gene in endometrial carcinoma].
Chao H; Sun J; Lu S
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):228-31. PubMed ID: 11778238
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.
Yanokura M; Banno K; Susumu N; Kawaguchi M; Kuwabara Y; Tsukazaki K; Aoki D
Anticancer Res; 2006; 26(2A):851-6. PubMed ID: 16619479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
